Nash dropout A Top Contender in the Race for a
Post# of 145445
![](/assets/46931549/no_avatar_available_thumb.jpg)
A Top Contender in the Race for a NASH Drug Drops Out
Josh Nathan-Kazis
July 23, 2020, 11:02 AM
French biotech Genfit, which had been expected to bring one of the first drugs to market to treat nonalcoholic steatohepatitis, said it is getting out of the race altogether.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)